In this task, you are given a multiple-choice question about healthcare. Answer the question based on your information and classify your answers into '1', '2', '3', and '4'.

Input: Consider Input: Question: Regarding intestinal polyposis, which of the following syndromes is NOT hereditary? 
 Options:  <1> Gardner syndrome. <2> Cronkhite-Canada syndrome. <3> Turcot syndrome. <4> Juvenile polyposis <5> Peutz-Jeghers syndrome.

Output: 2


Input: Consider Input: Question: A 16-year-old boy who consulted due to pultulose tonsillitis, fever up to 38.5ºC, painful cervical adenopathies, non-pruritic macular exanthema in the thorax and mild hepatosplenomegaly, 4-5 days old. The Paul-Bunnell test and the IgM for the Epstein-Barr virus are positive. During his admission he develops a continuous fever of up to 40ºC, pancytopenia, icteric hepatitis and coagulopathy of progressive intensity. One week after admission, he was transferred to the ICU due to confusion and respiratory failure. The blood cultures and a urine culture are negative, the CSF is normal and the chest plate does not show infiltrates. Procalcitonin is normal, but PCR and ferritin are very high. From the statements below, what would be the most correct diagnostic and therapeutic approach? 
 Options:  <1> It has a bacterial sepsis of undetermined origin and should be administered ceftriaxone and supportive treatment. <2> It has a bacterial sepsis of undetermined origin and should be administered vancomycin, ceftacidime and supportive treatment. <3> It is an infectious mononucleosis of severe course and glucocorticoids must be administered. <4> It is an infectious mononucleosis of severe course and treatment with acyclovir should be started. <5> Perform a biopsy / aspirate of bone marrow and if hemophagocytosis is confirmed, start treatment with immunosuppressants.

Output: 5


Input: Consider Input: Question: Regarding the designs of clinical trials to demonstrate efficacy of antidepressants, which of the following is FALSE? 
 Options:  <1> The inclusion in the design of clinical trials of secondary safety variables is important in order to establish the therapeutic location of the drugs studied. <2> In studies of depression it is not considered ethical to use a control group with placebo. <3> The efficacy of antidepressants is measured by the proportion of subjects with a predetermined percentage reduction in specific depression scales, such as Hamilton's or Beck's. <4> Due to the great variability of the response between one study and another, comparisons between active drugs with a noninferiority design do not allow to conclude efficacy in a robust way. <5> Although clinical improvement can be seen in one or two weeks, it usually takes 4 weeks of follow-up in clinical trials to establish significant differences.


Output: 2